Renaissance Technologies LLC has filed an updated Schedule 13G/A with the SEC, revealing its ownership of 4.84% of PetMed Express Inc.'s common stock. This filing, dated November 12, 2026, is significant as it indicates Renaissance's continued investment in the company, which operates within the retail-drug store sector.

Background

PetMed Express Inc. (Ticker: PETS) is a company based in Delray Beach, Florida, primarily involved in the retail-drug store industry, classified under SIC code 5912. The company specializes in providing pet medications and health products. Its recent filings include a 10-Q on November 10, 2026, and an 8-K on the same day, reflecting ongoing business activities.

What the Filing Says

The Schedule 13G/A filing states that Renaissance Technologies LLC beneficially owns 1,070,630 shares of PetMed Express, amounting to 4.84% of the company's common stock. The filing specifies that Renaissance has sole voting and dispositive power over these shares.

Impact

This increase in stake may influence the company's strategic direction and market perception. Renaissance Technologies, known for its quantitative trading strategies, may use its position to advocate for changes that align with its investment philosophy. The filing also indicates that certain funds managed by Renaissance have rights to dividends and proceeds from the sale of these securities.

What's Next

The filing does not say what happens next regarding Renaissance's investment strategy or any potential actions they may take with their increased stake in PetMed Express.